标题
The Potential of Antiviral Peptides as COVID-19 Therapeutics
作者
关键词
-
出版物
Frontiers in Pharmacology
Volume 11, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2020-09-15
DOI
10.3389/fphar.2020.575444
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein
- (2020) Shuai Xia et al. Cellular & Molecular Immunology
- A pneumonia outbreak associated with a new coronavirus of probable bat origin
- (2020) Peng Zhou et al. NATURE
- Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses
- (2020) Michael Letko et al. Nature Microbiology
- The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade
- (2020) B. Coutard et al. ANTIVIRAL RESEARCH
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion
- (2020) Shuai Xia et al. CELL RESEARCH
- Recent progress in understanding 2019 novel coronavirus (SARS-CoV-2) associated with human respiratory disease: detection, mechanisms and treatment
- (2020) Shuntong Kang et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
- (2020) Yeming Wang et al. LANCET
- Compassionate Use of Remdesivir for Patients with Severe Covid-19
- (2020) Jonathan Grein et al. NEW ENGLAND JOURNAL OF MEDICINE
- Unveiling ‘Warp Speed,’ the White House’s America-first push for a coronavirus vaccine
- (2020) Jon Cohen SCIENCE
- Rare driver mutations in head and neck squamous cell carcinomas converge on NOTCH signaling
- (2020) Sampath K. Loganathan et al. SCIENCE
- The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro
- (2020) Leon Caly et al. ANTIVIRAL RESEARCH
- Coronavirus breakthrough: dexamethasone is first drug shown to save lives
- (2020) Heidi Ledford NATURE
- Antiviral Activity of Synthetic Peptides Derived from Physiological Proteins
- (2019) Arianna Sala et al. INTERVIROLOGY
- A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike
- (2019) Shuai Xia et al. Science Advances
- Antiviral peptides as promising therapeutic drugs
- (2019) Liana Costa Pereira Vilas Boas et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Human Antimicrobial Peptides as Therapeutics for Viral Infections
- (2019) Aslaa Ahmed et al. Viruses-Basel
- Peptide Antiviral Strategies as an Alternative to Treat Lower Respiratory Viral Infections
- (2019) Origène Nyanguile Frontiers in Immunology
- Molecular mechanism of HIV-1 resistance to sifuvirtide, a clinical trial–approved membrane fusion inhibitor
- (2018) Danwei Yu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A novel peptide with potent and broad-spectrum antiviral activities against multiple respiratory viruses
- (2016) Hanjun Zhao et al. Scientific Reports
- Protective Effect of Intranasal Regimens Containing Peptidic Middle East Respiratory Syndrome Coronavirus Fusion Inhibitor Against MERS-CoV Infection
- (2015) Rudragouda Channappanavar et al. JOURNAL OF INFECTIOUS DISEASES
- Mechanism of HIV-1 Resistance to Short-Peptide Fusion Inhibitors Targeting the Gp41 Pocket
- (2015) Yang Su et al. JOURNAL OF VIROLOGY
- Perspective of Use of Antiviral Peptides against Influenza Virus
- (2015) Sylvie Skalickova et al. Viruses-Basel
- Conjugation of Cholesterol to HIV-1 Fusion Inhibitor C34 Increases Peptide-Membrane Interactions Potentiating Its Action
- (2013) Axel Hollmann et al. PLoS One
- Analysis and Prediction of Highly Effective Antiviral Peptides Based on Random Forests
- (2013) Kuan Y. Chang et al. PLoS One
- Virucidal activity of a scorpion venom peptide variant mucroporin-M1 against measles, SARS-CoV and influenza H5N1 viruses
- (2011) Qiaoli Li et al. PEPTIDES
- Structures of influenza A proteins and insights into antiviral drug targets
- (2010) Kalyan Das et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Sifuvirtide, a potent HIV fusion inhibitor peptide
- (2009) Rui-Rui Wang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Rhesus Theta-Defensin Prevents Death in a Mouse Model of Severe Acute Respiratory Syndrome Coronavirus Pulmonary Disease
- (2009) C. L. Wohlford-Lenane et al. JOURNAL OF VIROLOGY
- The spike protein of SARS-CoV — a target for vaccine and therapeutic development
- (2009) Lanying Du et al. NATURE REVIEWS MICROBIOLOGY
- Mucroporin, the First Cationic Host Defense Peptide from the Venom of Lychas mucronatus
- (2008) C. Dai et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Design and Evaluation of Sifuvirtide, a Novel HIV-1 Fusion Inhibitor
- (2008) Yuxian He et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started